JOIN THE BATTLE. Beat Rare Cancers.
Hello Twitter Boulder,
We are excited to kickoff a new tradition here at Twitter Boulder with the inaugural office ride to fundraise for Cycle for Survival!
Cycle for Survival is an event for people from across the country — cancer survivors, patients, caregivers, Memorial Sloan Kettering doctors, researchers, and their supporters — to ride together on stationary bikes to raise money to fight rare cancers.
In honor of our DES colleague Arielle Schwartz, who herself is a rare cancer survivor (here she is telling her story at the event last year), we are planning a Boulder ride at local spin studio Kondition Fitness on Friday, March 8th – the same day that Arielle and our friends at Twitter NYC will be saddling up.
Friday, March 8th
3161 Walnut St, Boulder, CO 80301
1:30 - 3:30pm
We have space for 40 Tweeps to ride!
Please let us know if you have any questions. Thanks for your support and hope you will join us!
- Maegan, Morgan and Linds
We are raising money for rare cancer research with Cycle for Survival, the movement to beat rare cancers. Will you help us surpass our fundraising goal?
Why this matters to us:
50% of People with Cancer Have a Rare Cancer
When combined, about half of all patients fighting cancer are fighting a rare cancer. These are cancers we know — such as leukemia, lymphoma, thyroid, ovarian, brain, pancreatic, and all pediatric cancers — yet research is largely underfunded.
100% Goes to Lifesaving Research Led by MSK
Every dollar you give will advance innovative studies and clinical trials led by Memorial Sloan Kettering Cancer Center (MSK). Discoveries made by MSK revolutionize how cancer is diagnosed and treated, helping patients across the country and around the world.
Join us or make a donation today. Your efforts will fight cancer and make a real impact for people who have few, if any, treatment options. As a donor, you will learn about the projects supported and the breakthroughs made.
Thank you in advance for your support!
JOIN THE BATTLE.
If you think this page contains objectionable content, please inform the system administrator.